Reuters logo
BRIEF-China Regenerative Medicine International says FY net loss HK$184.5 million
July 17, 2017 / 3:18 PM / 4 months ago

BRIEF-China Regenerative Medicine International says FY net loss HK$184.5 million

July 17 (Reuters) - China Regenerative Medicine International Ltd:

* Group’s revenue for year ended 30 April 2017 was approximately HK$357.0 million versus HK$27.8 million

* Directors do not recommend payment of a dividend for year ended 30 April 2017

* FY net loss HK$184.5 million versus loss HK$190.9 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below